Aflac stock: JPMorgan raises target to USD 119.00 for Aflac stock

Published on 10/21/2026 at 16:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Aflac reports third-quarter results on November 4, 2026. Aflac stock costs EUR 107.43 at Lang & Schwarz on October 21, 2026 at 4:33 p.m. CEST.

Target revision and reporting date

JPMorgan raised its Aflac target from USD 116.00 to USD 119.00 on October 15, 2026.
Aflac will release third-quarter 2026 results on November 4, 2026.
Aflac stock costs EUR 107.43 at Lang & Schwarz on October 21, 2026 at 4:33 p.m. CEST.

Makroaufnahme: Versicherungsvertrag mit Unterschriftenzeile im Detail — AFLAC Inc. macro photography of insurance contract signature section close-up detail, ISIN US0010551028 policy documentation, Illustration mit AI erstellt.

Aflac stock: JPMorgan raised its price target for Aflac from USD 116.00 to USD 119.00 on October 15, 2026, while maintaining a Neutral rating, according to Markets Insider. The target lies 1.36 percent below Aflac's NYSE price of USD 120.64 at 10:38 a.m. EDT on October 21, 2026. At Lang & Schwarz, the stock was trading at EUR 107.43 on October 21, 2026 at 4:33 p.m. CEST.

November results set the next marker

Aflac will release its third-quarter 2026 financial results after the NYSE close on November 4, 2026, the company said in a September 30, 2026 announcement. A conference call is scheduled for 8:00 a.m. ET on November 5, 2026, giving investors two dated checkpoints for the insurer's next reporting cycle. The announcement also identifies Aflac's listing as the NYSE under ticker AFL, according to Aflac.

Stock sits below its yearly high

The NYSE quote of USD 120.64 was 7.36 percent below the 52-week high of USD 130.22 and 14.39 percent above the 52-week low of USD 105.43 on October 21, 2026. Volume was 160,777 shares at 10:38 a.m. EDT, against an average volume of 1,989,534 shares. Those figures place the stock in the upper half of its annual range, but below the recent peak.

Valuation and dates matter

Aflac's market capitalization was USD 60.5 billion on October 21, 2026. The insurer reported second-quarter 2026 revenue of USD 4.12 billion, consolidated net income of USD 825.00 million and diluted earnings per share of USD 1.63 for the period ended June 30, 2026. The next scheduled dates are the results release on November 4, 2026 and the webcast on November 5, 2026.

What does the target imply?

JPMorgan's USD 119.00 target is USD 1.64 below the NYSE quote of USD 120.64, a modest gap in the same currency. The target revision therefore sits alongside a scheduled earnings date rather than replacing it as the next company-specific test. Aflac operates through U.S. and Japanese insurance businesses, with supplemental health and life products at the center of its offering.

Price and investor perspective

The euro quotation was EUR 107.43 at Lang & Schwarz on October 21, 2026 at 4:33 p.m. CEST. The separate NYSE quotation was USD 120.64 on October 21, 2026 at 10:38 a.m. EDT. Together, the two quotations place the upcoming November report and JPMorgan's USD 119.00 target at the center of the near-term investor calendar. The further course of trading is shown by the continuously updated real-time quote of Aflac stock.